Brian JG Pereira - Nov 12, 2025 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role: Director
Signature: /s/ Todd Girolamo, attorney in fact
Stock symbol: PROK
Transactions as of: Nov 12, 2025
Transactions value $: -$1,884,577
Form type: 4
Date filed: 11/14/2025, 04:07 PM
Previous filing: Oct 2, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Pereira Brian JG	Director	C/O PROKIDNEY CORP, 2000 FRONTIS PLAZA BLVD, SUITE 250, WINSTON SALEM	/s/ Todd Girolamo, attorney in fact	2025-11-14	0001298146

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PROK	Class A Common Stock	Sale	-$619K	-227K	-33.68%	$2.72	448K	Nov 12, 2025	By Brian J. G. Pereira 2012 Irrevocable Trust	F1
transaction	PROK	Class A Common Stock	Sale	-$75.2K	-27.6K	-33.68%	$2.72	54.3K	Nov 12, 2025	Brian J. G. Pereira 2004 Trust	F1
transaction	PROK	Class A Common Stock	Sale	-$1.06M	-448K	-100%	$2.37	0	Nov 13, 2025	By Brian J. G. Pereira 2012 Irrevocable Trust	F2
transaction	PROK	Class A Common Stock	Sale	-$129K	-54.3K	-100%	$2.37	0	Nov 13, 2025	Brian J. G. Pereira 2004 Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote